These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2404076)

  • 1. Patterns of immune response among survivors of group B streptococcal meningitis.
    Edwards MS; Hall MA; Rench MA; Baker CJ
    J Infect Dis; 1990 Jan; 161(1):65-70. PubMed ID: 2404076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of complement and antibody in opsonophagocytosis of type II group B streptococci.
    Baker CJ; Webb BJ; Kasper DL; Edwards MS
    J Infect Dis; 1986 Jul; 154(1):47-54. PubMed ID: 3519791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of high serum IgM among mothers of infants with neonatal group-B streptococcal septicemia.
    Rundgren AK; Christensen KK; Christensen P
    Int Arch Allergy Appl Immunol; 1985; 77(3):372-3. PubMed ID: 3891636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.
    Baker CJ; Edwards MS; Kasper DL
    Pediatrics; 1981 Oct; 68(4):544-9. PubMed ID: 7033911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
    Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
    Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new flow-cytometry-based opsonophagocytosis assay for the rapid measurement of functional antibody levels against Group B Streptococcus.
    Fabbrini M; Sammicheli C; Margarit I; Maione D; Grandi G; Giuliani MM; Mori E; Nuti S
    J Immunol Methods; 2012 Apr; 378(1-2):11-9. PubMed ID: 22309986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of intravenous immune globulin for group B streptococcal infection.
    Baker CJ; Noya FJ
    Rev Infect Dis; 1990; 12 Suppl 4():S476-82. PubMed ID: 2194272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.
    Albanyan EA; Edwards MS
    Infect Immun; 2000 Oct; 68(10):5794-802. PubMed ID: 10992487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of IgM antibody to group B Streptococcus type III in human infants.
    Boyer KM; Klegerman ME; Gotoff SP
    J Infect Dis; 1992 Jun; 165(6):1049-55. PubMed ID: 1583322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.
    Choi MJ; Noh JY; Cheong HJ; Kim WJ; Lin SM; Zhi Y; Lim JH; Lim S; Seo HS; Song JY
    Hum Vaccin Immunother; 2018 Jan; 14(1):67-73. PubMed ID: 28933634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models.
    Givner LB; Edwards MS; Baker CJ
    J Infect Dis; 1988 Oct; 158(4):724-30. PubMed ID: 3049837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of circulating group B streptococcal immune complexes in neonates with meningitis.
    Vallejo JG; Baker CJ; Edwards MS
    J Clin Microbiol; 1994 Sep; 32(9):2041-5. PubMed ID: 7814522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
    Baker CJ; Edwards MS; Webb BJ; Kasper DL
    J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci.
    Shigeoka AO; Jensen CL; Pincus SH; Hill HR
    J Infect Dis; 1984 Jul; 150(1):63-70. PubMed ID: 6379061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus.
    Baker CJ; Kasper DL
    J Infect Dis; 1977 Aug; 136 Suppl():S98-104. PubMed ID: 70493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods of assessment and importance of opsonic activity for GBS.
    Hill HR; Shigeoka AO; Rote NS; Allred CD; Hemming VG
    Antibiot Chemother (1971); 1985; 35():157-69. PubMed ID: 3901892
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.
    Wessels MR; Butko P; Ma M; Warren HB; Lage AL; Carroll MC
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11490-4. PubMed ID: 8524789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune globulin for intravenous use: enhancement of in vitro opsonophagocytic activity of neonatal serum.
    Givner LB; Edwards MS; Anderson DC; Baker CJ
    J Infect Dis; 1985 Feb; 151(2):217-20. PubMed ID: 3918123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.